Aandeel XENE XENON PHARMACEUTICALS INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Xenon Pharmaceuticals Inc.

Aandelen

XENE

CA98420N1050

Beurs gesloten - Nasdaq
Andere beurzen
 22:00:00 26-06-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
36,57 USD -1,16% Intraday-grafiek van Xenon Pharmaceuticals Inc. +0,88% -20,60%
12/06 Transcript : Xenon Pharmaceuticals Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 04:00 PM
04/06 Transcript : Xenon Pharmaceuticals Inc. - Shareholder/Analyst Call

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual Meeting
Xenon Pharmaceuticals Inc. Presents Data from Phase 2 X-Nova Clinical Trial of Azetukalner in Major Depressive Disorder At the American Society of Clinical Psychopharmacology 2024 Annual Meeting
Encephalopathy Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated)
Xenon Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Xenon Pharmaceuticals Q1 Net Loss Narrows
Xenon Pharmaceuticals: Q1 Earnings Snapshot
Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024
Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update
Xenon Pharmaceuticals Inc. Announces Board Resignations
Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting
Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days
Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days
Xenon Pharmaceuticals Insider Sold Shares Worth $330,290, According to a Recent SEC Filing
Xenon Pharmaceuticals Insider Sold Shares Worth $601,615, According to a Recent SEC Filing
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers XENE
  4. Nieuws Xenon Pharmaceuticals Inc.
  5. Andere talen